VanEck Biotech ETF

$195.150.02 %$BBH

About VanEck Biotech ETF (BBH)

VanEck Biotech ETF (BBH) is an exchange-traded fund established on December 20, 2011 and traded on the NASDAQ exchange. The fund manages approximately $0.39 billion in net assets, making it a significant ETF in its category.

With an expense ratio of 0.35%, VanEck Biotech ETF is considered a low-cost investment option for investors seeking exposure to this asset class.

The fund currently offers a dividend yield of 0.49%, providing income-seeking investors with supplemental distributions alongside potential capital appreciation.

What You Need to Know About BBH

  • Inception Date: December 20, 2011 - providing 14 years of track record
  • Assets Under Management: $0.39 billion in net assets
  • Expense Ratio: 0.35% annually
  • Dividend Yield: 0.49% annual yield
  • Exchange: NASDAQ
  • Type: Traditional ETF

Compare BBH with other investment options: ETF Screener | Stock Screener

Price History

-0.28%

Fund Details

Dividend Yield0.49%
Inception Date2011-12-20
Net Assets$390.6M
Net Expense Ratio0.00%